AtriCure Inc reports results for the quarter ended December 31 - Earnings Summary

• AtriCure Inc ATRC.OQ reported a quarterly adjusted loss of 8 cents​​ per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of -21 cents. The mean expectation of nine analysts for the quarter was for a loss of 23 cents per share. Wall Street expected results to range from -41 cents to -9 cents per share.

• Revenue rose 16.6% to $124.28 million from a year ago; analysts expected $121.84 million.

• AtriCure Inc's reported EPS for the quarter was a loss of 33 cents​.

• The company reported a quarterly loss of $15.57 million.

• AtriCure Inc shares had risen by 35.8% this quarter.

FORECAST CHANGES

• The mean earnings estimate of analysts had risen by about 1.5% in the last three months.​

• In the last 30 days, there have been no negative revisions of earnings estimates

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 9 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

• The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "buy"

Wall Street's median 12-month price target for AtriCure Inc is $45.50

This summary was machine generated from LSEG data February 12 at 10:01 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)